| Immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women YC Ai-ris, K McMahan, J Yu, LH Tostanoski, R Aguayo, J Ansel, ... Jama 325 (23), 2370-2380, 2021 | 435 | 2021 |
| Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron J Liu, A Chandrashekar, D Sellers, J Barrett, C Jacob-Dolan, M Lifton, ... Nature 603 (7901), 493-496, 2022 | 373 | 2022 |
| Differential kinetics of immune responses elicited by Covid-19 vaccines AY Collier, J Yu, K McMahan, J Liu, A Chandrashekar, JS Maron, C Atyeo, ... New England Journal of Medicine 385 (21), 2010-2012, 2021 | 241 | 2021 |
| Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccine MS Gebre, S Rauch, N Roth, J Yu, A Chandrashekar, NB Mercado, X He, ... Nature 601 (7893), 410-414, 2022 | 98 | 2022 |
| Vaccine protection against the SARS-CoV-2 Omicron variant in macaques A Chandrashekar, J Yu, K McMahan, C Jacob-Dolan, J Liu, X He, D Hope, ... Cell 185 (9), 1549-1555. e11, 2022 | 70 | 2022 |
| Characterization of immune responses in fully vaccinated individuals after breakthrough infection with the SARS-CoV-2 delta variant AY Collier, CM Brown, KA McMahan, J Yu, J Liu, C Jacob-Dolan, ... Science translational medicine 14 (641), eabn6150, 2022 | 51 | 2022 |
| Protective efficacy of Ad26. COV2. S against SARS-CoV-2 B. 1.351 in macaques J Yu, LH Tostanoski, NB Mercado, K McMahan, J Liu, C Jacob-Dolan, ... Nature 596 (7872), 423-427, 2021 | 46 | 2021 |
| Vaccines elicit highly cross-reactive cellular immunity to the SARS-CoV-2 omicron variant J Liu, A Chandrashekar, D Sellers, J Barrett, M Lifton, K McMahan, ... MedRxiv, 2022 | 35 | 2022 |
| Coronavirus disease 2019 messenger RNA vaccine immunogenicity in immunosuppressed individuals AY Collier, J Yu, K McMahan, J Liu, C Atyeo, JL Ansel, ZP Fricker, ... The Journal of infectious diseases 225 (7), 1124-1128, 2022 | 22 | 2022 |
| Characterization of immune responses in fully vaccinated individuals following breakthrough infection with the SARS-CoV-2 delta variant AY Collier, CM Brown, KA McMahan, J Yu, J Liu, C Jacob-Dolan, ... Science Translational Medicine, eabn6150, 2022 | 20 | 2022 |
| Immune responses in fully vaccinated individuals following breakthrough infection with the SARS-CoV-2 Delta variant in Provincetown, Massachusetts AY Collier, CM Brown, K Mcmahan, J Yu, J Liu, C Jacob-Dolan, ... Medrxiv, 2021.10. 18.21265113, 2021 | 17 | 2021 |
| A homologous or variant booster vaccine after Ad26. COV2. S immunization enhances SARS-CoV-2–specific immune responses in rhesus macaques X He, M Aid, A Chandrashekar, J Yu, K McMahan, F Wegmann, ... Science Translational Medicine 14 (638), eabm4996, 2022 | 16 | 2022 |
| Prior infection with SARS-CoV-2 WA1/2020 partially protects rhesus macaques against reinfection with B. 1.1. 7 and B. 1.351 variants A Chandrashekar, J Liu, J Yu, K McMahan, LH Tostanoski, ... Science translational medicine 13 (618), eabj2641, 2021 | 15 | 2021 |
| Homologous and heterologous vaccine boost strategies for humoral and cellular immunologic coverage of the SARS-CoV-2 omicron variant CS Tan, AY Collier, J Liu, J Yu, A Chandrashekar, K McMahan, H Wan, ... MedRxiv, 2021.12. 02.21267198, 2021 | 11 | 2021 |
| Immunogenicity and protective efficacy of GBP510/AS03 vaccine against SARS-CoV-2 delta challenge in rhesus macaques C Jacob-Dolan, J Yu, K McMahan, V Giffin, A Chandrashekar, AJ Martinot, ... npj Vaccines 8 (1), 23, 2023 | 9 | 2023 |
| Optimization of non-coding regions improves protective efficacy of an mRNA SARS-CoV-2 vaccine in nonhuman primates MS Gebre, S Rauch, N Roth, J Yu, A Chandrashekar, NB Mercado, X He, ... BioRxiv, 2021.08. 13.456316, 2021 | 8 | 2021 |
| Ad26. COV2. S or BNT162b2 boosting of BNT162b2 vaccinated individuals CS Tan, AY Collier, J Liu, J Yu, H Wan, K McMahan, X He, C Jacob-Dolan, ... medRxiv, 2021 | 6 | 2021 |
| Protective efficacy of gastrointestinal SARS-CoV-2 delivery against intranasal and intratracheal SARS-CoV-2 challenge in rhesus macaques J Yu, ND Collins, NB Mercado, K McMahan, A Chandrashekar, J Liu, ... Journal of virology 96 (2), e01599-21, 2022 | 5 | 2022 |
| A bivalent SARS-CoV-2 monoclonal antibody combination does not affect the immunogenicity of a vector-based COVID-19 vaccine in macaques JP Nkolola, J Yu, H Wan, A Chang, K McMahan, T Anioke, C Jacob-Dolan, ... Science Translational Medicine 14 (665), eabo6160, 2022 | 4 | 2022 |
| Passive transfer of Ad26. COV2. S-elicited IgG from humans attenuates SARS-CoV-2 disease in hamsters LH Tostanoski, A Chandrashekar, S Patel, J Yu, C Jacob-Dolan, A Chang, ... npj Vaccines 7 (1), 2, 2022 | 4 | 2022 |
